April 8th 2021, 1:00pm
If you missed any part of CURE®’s Educated Patient® Breast Cancer Summit, take a look at this roundup of stories that highlight the expert insight and guidance that was shared throughout the day.
April 7th 2021, 8:29pm
Approximately one year after granting Trodelvy accelerated approval, the Food and Drug Administration granted a regular approval to the antibody-drug conjugate in certain patients with pretreated triple-negative breast cancer.
April 7th 2021, 6:00pm
Men with breast cancer who were treated with Soltamox plus gonadotropin-releasing hormone analogue had a decrease in estradiol levels of 85%, whereas Aromasin plus gonadotropin-releasing hormone analogue reduced these levels by 72%.
April 4th 2021, 3:00pm
The Food and Drug Administration’s Oncologic Drugs Advisory Committee unanimously voted in favor of waiting for more data before making an approval decision involving the use of Keytruda in early triple-negative breast cancer.
April 1st 2021, 3:00pm
Dr. John Marshall and his wife, Liza, look back on the trials and tribulations of Liza’s triple-negative breast cancer diagnosis – from the perspective of a patient and her husband, the caregiver and oncologist.
March 26th 2021, 6:00pm
Although Keytruda did not improve overall survival when compared with chemotherapy, patients with a higher PD-L1 expression may derive a greater benefit with Keytruda, as shown with a longer median overall survival.
March 26th 2021, 3:00pm
From a Baltimore restaurant owner traveling six hours to cook for a terminally ill customer to the death of a pioneer in breast cancer treatment, here’s what’s happening in the cancer landscape this week.
March 23rd 2021, 6:00pm
Data from a recent study demonstrates that patients with breast cancer — especially those who are younger, privately insured, of non-White race and lower-income — are more likely to file for bankruptcy than those without cancer.
March 18th 2021, 6:00pm
Postponing tests or doctor visits during the pandemic may increase women’s risk of cancer.
March 18th 2021, 4:00pm
Why do some survive cancer, while others don’t? And why do those who survive often feel the aches of survivor’s guilt? Here, a survivor shares how she learned to cope.
Ayvakit Shows Promise for Patients with Gastrointestinal Stomach Tumors With Specific Mutation
Survivorship Champions
FDA Approves Opdivo for the Frontline Treatment of Gastric Cancer
Learning to be a Kinder Person After Cancer
